数据中心
龙虎榜
大单追踪
资金流向
业绩预告
新股申购
行情中心
沪深市场
香港市场
美国市场
全球市场
行业风云
全球市场
向上 向下

   PTX
-- -- --

今开：-- 昨收：-- 最高：-- 最低：--
成交量：--万手 市盈率：-- 总市值($)：-- 换手率：--
加入自选股

首页概览 公司概况 财务分析 高管介绍 股本结构 公司新闻

股本结构

单位：万股
公告日期 2018-11-13 2018-11-13 2018-08-09 2018-08-09 2018-05-10 2018-04-09
证券总股本 1450.58 1395.77 1392.03 1206.55 1187.36 1187.36
普通股本 1450.58 1395.77 1392.03 1206.55 1187.36 1187.36
优先股 未披露 8.10 未披露 未披露 未披露 未披露
其他 未披露 未披露 未披露 未披露 未披露 未披露
变动日期 2018-11-06 2018-09-30 2018-08-06 2018-06-30 2018-03-31 2018-03-28
注释：中概股证券总股本=普通股股本/ 存托凭证比例

历史变动

公告日期 变动后普通股本（万股） 变动后优先股（万股） 变动原因 变动日期
2018-11-13 1450.58 未披露 定期报告 2018-11-06
2018-11-13 1395.77 8.10
更多>>
from December 31, 2017 to September 30, 2018 Treximet Secured Notes Conversion Conversion of restricted stock units Net proceeds from sale of shares
2018-09-30
2018-08-09 1392.03 未披露 定期报告 2018-08-06
2018-08-09 1206.55 未披露
更多>>
from December 31, 2017 to June 30, 2018 Conversion of restricted stock units Net proceeds from sale of shares
2018-06-30
2018-05-10 1187.36 未披露
更多>>
from December 31, 2017 to March 31, 2018 Conversion of restricted stock units
2018-03-31
2018-04-09 1187.36 未披露 定期报告 2018-03-28
2018-03-08 1187.28 未披露 定期报告 2018-03-01
2018-03-08 1184.12 未披露
更多>>
from December 31, 2016 to December 31, 2017 Conversion of restricted stock units Issuance of Convertible Debt Net proceeds from sale of shares
2017-12-31
2017-11-22 1164.14 未披露 定期报告 2017-11-22
2017-11-07 1153.24 未披露
更多>>
From December 31, 2016 To September 30, 2017 Net proceeds from issuance of restricted stock Net proceeds from sale of shares Net proceeds from exchange of debt
2017-09-30
2017-09-27 1153.24 未披露 定期报告 2017-09-25
2017-07-24 1111.61 未披露 定期报告 2017-07-21
2017-03-28 1001.56 未披露
更多>>
from December 31, 2015 to December 31, 2016 Net proceeds from issuance of restricted stock Net proceeds from sale of shares Reclassification of treasury stock On October 13, 2016, Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), today announced that its Board of Directors unanimously approved a reverse split of its common stock at a ratio of 1-for-10. The reverse stock split will become effective as of the close of business on October 13, 2016, with anticipated trading on the post-split basis on NASDAQ commencing at the open of the stock market on October 14, 2016.
2016-12-31
2016-11-10 949.98 未披露
更多>>
On October 13, 2016, Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), today announced that its Board of Directors unanimously approved a reverse split of its common stock at a ratio of 1-for-10. The reverse stock split will become effective as of the close of business on October 13, 2016, with anticipated trading on the post-split basis on NASDAQ commencing at the open of the stock market on October 14, 2016.
2016-10-14
2016-08-11 8512.01 未披露 定期报告 2016-06-30
2016-05-05 6112.80 未披露 定期报告 2016-03-31
2016-03-10 6112.76 未披露 定期报告 2016-03-03
2016-03-10 6111.25 未披露
更多>>
From December 31, 2014 to December 31, 2015 Net proceeds from issuance of restricted stock Net proceeds from sale of shares Conversion of 8.0% convertible notes Issuance of stock for inducement Stock issued in connection with the purchase of Zohydro ER
2015-12-31
2015-11-05 6105.73 未披露 定期报告 2015-09-30
2015-08-06 6103.78 未披露 定期报告 2015-07-30
2015-08-06 6079.12 未披露 定期报告 2015-06-30
2015-05-01 4354.01 未披露 定期报告 2015-04-24
2015-05-08 3887.25 未披露 定期报告 2015-04-20
2015-05-01 3887.20 未披露 定期报告 2015-03-31
2015-03-02 3838.64 未披露 定期报告 2015-02-25
2015-03-02 3834.10 未披露
更多>>
from December 31, 2013 to December 31, 2014 Issuance of common stock upon the exercise of stock options, net of tax Issuance of common stock upon the vesting of restricted stock Forfeit of restricted common stock in payment of income tax liability Issuance of common stock in connection with employee stock purchase plan Issuance of common stock upon the cashless exercise of options from non-employees
2014-12-31
2014-11-10 3829.17 未披露 定期报告 2014-11-07
2014-11-10 3820.41 未披露
更多>>
from December 31, 2013 to September 30, 2014 Issuance of common stock upon the exercise of options, net of tax Issuance of common stock upon the cashless exercise of options from non-employees Issuance of common stock in connection with the Employee stock purchase plan Issuance of common stock upon the vesting of restricted stock Forfeiture of restricted common stock resulting from payment of employee income tax liability
2014-09-30
2014-08-11 3804.39 未披露 定期报告 2014-08-08
2014-08-11 3802.49 未披露
更多>>
from December 31, 2013 to June 30, 2014 Issuance of common stock upon the exercise of stock options Issuance of common stock upon the cashless exercise of options from non-employees Issuance of common stock in connection with the Employee stock purchase plan Issuance of common stock upon the vesting of restricted stock Forfeit of restricted common stock resulting from payment of employee income tax liability
2014-06-30
2014-05-12 3777.31 未披露 定期报告 2014-05-09
2014-04-28 3775.29 未披露 定期报告 2014-04-21
2014-05-12 3750.29 未披露
更多>>
from December 31, 2013 to March 31, 2014 Issuance of common stock upon the exercise of stock options Issuance of common stock upon vesting of restricted stock Forfeit of restricted stock in payment of income tax liability
2014-03-31
2014-03-17 3735.43 未披露 定期报告 2014-03-12
2014-03-17 3718.94 未披露
更多>>
from December 31, 2012 to December 31, 2013 Restricted stock Cancelled/reclass par value of unvested restricted stock Issuance of common stock upon the exercise of stock options Forfeit of restricted common stock in payment of income tax liability Issuance of common stock in connection with employee stock purchase plan Issuance of restricted stock in lieu of cash payment Issuance of common stock in connection with the Somaxon acquisition Reclass of shares (previously subject to the put right of the former Cypress shareholders in connection with the Cypress acquisition) from temporary equity
2013-12-31
2013-11-12 3716.45 未披露 定期报告 2013-11-08
2013-11-12 3778.36 未披露
更多>>
from December 31, 2012 to September 30, 2013 Stock-based compensation Cancelled/reclass par of unvested restricted stock Issuance of common stock upon the exercise of options Issuance of common stock in connection with employee stock purchase plan Forfeit of restricted common stock in payment of income tax liability Issuance of common stock in connection with the Somaxon acquisition Issuance of restricted stock in lieu of cash payment Cancellation of Put Shares
2013-09-30
2013-08-09 3712.09 未披露
更多>>
from December 31, 2012 to June 30, 2013 Stock-based compensation Cancelled/reclass par of unvested restricted stock Issuance of common stock upon the exercise of options Issuance of common stock in connection with employee stock purchase plan Forfeit of restricted common stock in payment of income tax liability Issuance of common stock in connection with the Somaxon acquisition Issuance of restricted stock in lieu of cash payment Cancellation of Put Shares
2013-06-30
2013-05-10 3760.44 未披露 定期报告 2013-05-08
2013-04-26 3758.43 未披露 定期报告 2013-04-22
2013-05-10 3749.52 未披露
更多>>
From December 31, 2012 to March 31, 2013 Cancelled unvested restricted stock Issuance of common stock, net of stock withheld for income tax liability Forfeit of restricted common stock in payment of income tax liability Issuance of common stock in connection with the Somaxon acquisition
2013-03-31
2013-03-18 3772.41 未披露 定期报告 2013-03-15
2013-03-18 3403.04 未披露
更多>>
from December 31, 2011 to December 31, 2012 Restricted stock Issuance of common stock in lieu of cash bonus Issuance of common stock upon the exercise of stock optionsIssuance of common stock in connection with employee stock purchase plan Issuance of common stock upon additional public offering, net of issuance costs of $846,202
2012-12-31
2012-11-14 2911.34 未披露 定期报告 2012-11-12
2012-11-14 2907.08 未披露
更多>>
from December 31, 2011 to September 30, 2012 Stock-based compensation Issuance of common stock, net of stock withheld for income tax liability Issuance of common stock upon additional public offering, net of issuance costs of $846,202
2012-09-30
2012-08-14 2906.82 未披露
更多>>
from December 31, 2011 to May 11,2012 Stock-based compensation Issuance of common stock, net of stock withheld for income tax liability Issuance of common stock upon additional public offering, net of issuance costs of $846,202
2012-05-11
2012-05-15 2635.07 未披露
更多>>
from December 31, 2011 to March 31, 2012 Stock-based compensation Issuance of common stock, net of stock withheld for income tax liability Issuance of common stock upon additional public offering, net of issuance costs of $185,871
2012-03-31
2012-03-29 2603.43 未披露 定期报告 2012-03-23
2012-03-29 2574.91 未披露
更多>>
from December 31, 2010 to December 31, 2011 Restricted stock Issuance of common stock upon the exercise of stock options Issuance of common stock in connection with employee stock purchase plan Issuance of common stock upon registered direct offering, net of issuance costs of $255,254
2011-12-31
2011-11-14 2574.28 未披露 定期报告 2011-11-11
2011-11-14 2572.51 未披露
更多>>
FROM December 31, 2010 TO September 30, 2011 Restricted stock Issuance of common stock upon the exercise of stock options Issuance of common stock in connection with employee stock purchase plan Issuance of common stock upon additional public offering, net of issuance costs of $255,254
2011-09-30
2011-08-15 2570.84 未披露 定期报告 2011-08-12
2011-08-15 2270.57 未披露
更多>>
from December 31, 2010 to June 30, 2011 Stock-based compensation: Restricted stock Exercise of stock options Shares issued in connection with employee stock purchase plan
2011-06-30
2011-05-16 2268.77 未披露
更多>>
from December 31, 2010 to March 25,2011 Stock-based compensation: Restricted stock
2011-03-25
2011-03-30 2262.77 未披露
更多>>
from December 31, 2009 to November 9,2010 Transfer of equity in reverse merger with GTA Stock repurchase program:Open market repurchases Stock repurchase program:Negotiated repurchase from related party Proceeds from issuance of stock Stock-based compensation:Restricted stock
2010-11-09
2010-11-12 2263.85 未披露
更多>>
from December 31, 2009 to September 30, 2010 Transfer of equity in reverse merger with GTA Stock repurchase program:Open market repurchases Stock repurchase program:Negotiated repurchase from related party Proceeds from issuance of stock Issuance of restricted stock
2010-09-30
2010-08-16 2468.13 未披露 定期报告 2010-08-12
2010-08-16 2469.07 未披露
更多>>
from December 31, 2009 to June 30, 2010 Transfer of equity in reverse merger with GTA Purchase of stock Proceeds from issuance of stock Issuance of restricted stock
2010-06-30
2010-05-14 2455.86 未披露
更多>>
from December 31, 2009 to March 31, 2010 Transfer of equity in reverse merger with GTA
2010-03-31
2008-03-31 731.72 未披露 定期报告 2007-12-31
2006-04-17 731.72 80.00 定期报告 2006-04-12
2005-03-30 737.28 80.00 定期报告 2005-03-24
2003-03-31 788.49 80.00 定期报告 2003-03-24
2002-04-01 777.81 未披露 定期报告 2002-03-22
2002-04-01 911.00 80.00
更多>>
from December 31, 2000 to May 22, 2001 Conversion/redemption of OP units Issuance of shares under employee stock purchase plan
2001-05-22
2001-03-14 821.76 未披露 定期报告 2001-03-05
2001-03-14 815.55 80.00
更多>>
from December 31, 1999 to December 31, 2000 Issuance of restricted stock Conversion/redemption of OP Units Stock repurchase program Issuance of shares under employee stock purchase plan
2000-12-31
2000-03-30 811.81 80.00 定期报告 2000-03-22
2000-03-30 773.65 80.00
更多>>
from December 31, 1998 to December 31, 1999 Issuance and cancellation of restricted stock Issuance of preferred stock Conversion of OP Units into common stock Issuance of shares of employee stock purchase plan
1999-12-31
1999-03-31 768.30 未披露 定期报告 1999-03-26
1999-03-31 763.75 未披露
更多>>
from December 31, 1997 to December 31, 1998 Issuance of restricted stock Issuance of shares for option exercise and employee stock purchase plans
1998-12-31
1998-03-31 763.17 未披露 定期报告 1998-03-15
1998-03-31 761.08 未披露
更多>>
from February 12, 1997 to December 31, 1997 Proceeds from Initial Public Offering Issuance of shares in exchange for note Issuance of shares for acquisition Issuance of restricted stock Proceeds from follow-on offering
1997-12-31
1997-03-31 0.0001 未披露 定期报告 1996-12-31
from December 31, 2017 to September 30, 2018 Treximet Secured Notes Conversion Conversion of restricted stock units Net proceeds from sale of shares
from December 31, 2017 to June 30, 2018 Conversion of restricted stock units Net proceeds from sale of shares
from December 31, 2017 to March 31, 2018 Conversion of restricted stock units
from December 31, 2016 to December 31, 2017 Conversion of restricted stock units Issuance of Convertible Debt Net proceeds from sale of shares
From December 31, 2016 To September 30, 2017 Net proceeds from issuance of restricted stock Net proceeds from sale of shares Net proceeds from exchange of debt
from December 31, 2015 to December 31, 2016 Net proceeds from issuance of restricted stock Net proceeds from sale of shares Reclassification of treasury stock On October 13, 2016, Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), today announced that its Board of Directors unanimously approved a reverse split of its common stock at a ratio of 1-for-10. The reverse stock split will become effective as of the close of business on October 13, 2016, with anticipated trading on the post-split basis on NASDAQ commencing at the open of the stock market on October 14, 2016.
On October 13, 2016, Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), today announced that its Board of Directors unanimously approved a reverse split of its common stock at a ratio of 1-for-10. The reverse stock split will become effective as of the close of business on October 13, 2016, with anticipated trading on the post-split basis on NASDAQ commencing at the open of the stock market on October 14, 2016.
From December 31, 2014 to December 31, 2015 Net proceeds from issuance of restricted stock Net proceeds from sale of shares Conversion of 8.0% convertible notes Issuance of stock for inducement Stock issued in connection with the purchase of Zohydro ER
from December 31, 2013 to December 31, 2014 Issuance of common stock upon the exercise of stock options, net of tax Issuance of common stock upon the vesting of restricted stock Forfeit of restricted common stock in payment of income tax liability Issuance of common stock in connection with employee stock purchase plan Issuance of common stock upon the cashless exercise of options from non-employees
from December 31, 2013 to September 30, 2014 Issuance of common stock upon the exercise of options, net of tax Issuance of common stock upon the cashless exercise of options from non-employees Issuance of common stock in connection with the Employee stock purchase plan Issuance of common stock upon the vesting of restricted stock Forfeiture of restricted common stock resulting from payment of employee income tax liability
from December 31, 2013 to June 30, 2014 Issuance of common stock upon the exercise of stock options Issuance of common stock upon the cashless exercise of options from non-employees Issuance of common stock in connection with the Employee stock purchase plan Issuance of common stock upon the vesting of restricted stock Forfeit of restricted common stock resulting from payment of employee income tax liability
from December 31, 2013 to March 31, 2014 Issuance of common stock upon the exercise of stock options Issuance of common stock upon vesting of restricted stock Forfeit of restricted stock in payment of income tax liability
from December 31, 2012 to December 31, 2013 Restricted stock Cancelled/reclass par value of unvested restricted stock Issuance of common stock upon the exercise of stock options Forfeit of restricted common stock in payment of income tax liability Issuance of common stock in connection with employee stock purchase plan Issuance of restricted stock in lieu of cash payment Issuance of common stock in connection with the Somaxon acquisition Reclass of shares (previously subject to the put right of the former Cypress shareholders in connection with the Cypress acquisition) from temporary equity
from December 31, 2012 to September 30, 2013 Stock-based compensation Cancelled/reclass par of unvested restricted stock Issuance of common stock upon the exercise of options Issuance of common stock in connection with employee stock purchase plan Forfeit of restricted common stock in payment of income tax liability Issuance of common stock in connection with the Somaxon acquisition Issuance of restricted stock in lieu of cash payment Cancellation of Put Shares
from December 31, 2012 to June 30, 2013 Stock-based compensation Cancelled/reclass par of unvested restricted stock Issuance of common stock upon the exercise of options Issuance of common stock in connection with employee stock purchase plan Forfeit of restricted common stock in payment of income tax liability Issuance of common stock in connection with the Somaxon acquisition Issuance of restricted stock in lieu of cash payment Cancellation of Put Shares
From December 31, 2012 to March 31, 2013 Cancelled unvested restricted stock Issuance of common stock, net of stock withheld for income tax liability Forfeit of restricted common stock in payment of income tax liability Issuance of common stock in connection with the Somaxon acquisition
from December 31, 2011 to December 31, 2012 Restricted stock Issuance of common stock in lieu of cash bonus Issuance of common stock upon the exercise of stock optionsIssuance of common stock in connection with employee stock purchase plan Issuance of common stock upon additional public offering, net of issuance costs of $846,202
from December 31, 2011 to September 30, 2012 Stock-based compensation Issuance of common stock, net of stock withheld for income tax liability Issuance of common stock upon additional public offering, net of issuance costs of $846,202
from December 31, 2011 to May 11,2012 Stock-based compensation Issuance of common stock, net of stock withheld for income tax liability Issuance of common stock upon additional public offering, net of issuance costs of $846,202
from December 31, 2011 to March 31, 2012 Stock-based compensation Issuance of common stock, net of stock withheld for income tax liability Issuance of common stock upon additional public offering, net of issuance costs of $185,871
from December 31, 2010 to December 31, 2011 Restricted stock Issuance of common stock upon the exercise of stock options Issuance of common stock in connection with employee stock purchase plan Issuance of common stock upon registered direct offering, net of issuance costs of $255,254
FROM December 31, 2010 TO September 30, 2011 Restricted stock Issuance of common stock upon the exercise of stock options Issuance of common stock in connection with employee stock purchase plan Issuance of common stock upon additional public offering, net of issuance costs of $255,254
from December 31, 2010 to June 30, 2011 Stock-based compensation: Restricted stock Exercise of stock options Shares issued in connection with employee stock purchase plan
from December 31, 2010 to March 25,2011 Stock-based compensation: Restricted stock
from December 31, 2009 to November 9,2010 Transfer of equity in reverse merger with GTA Stock repurchase program:Open market repurchases Stock repurchase program:Negotiated repurchase from related party Proceeds from issuance of stock Stock-based compensation:Restricted stock
from December 31, 2009 to September 30, 2010 Transfer of equity in reverse merger with GTA Stock repurchase program:Open market repurchases Stock repurchase program:Negotiated repurchase from related party Proceeds from issuance of stock Issuance of restricted stock
from December 31, 2009 to June 30, 2010 Transfer of equity in reverse merger with GTA Purchase of stock Proceeds from issuance of stock Issuance of restricted stock
from December 31, 2009 to March 31, 2010 Transfer of equity in reverse merger with GTA
from December 31, 2000 to May 22, 2001 Conversion/redemption of OP units Issuance of shares under employee stock purchase plan
from December 31, 1999 to December 31, 2000 Issuance of restricted stock Conversion/redemption of OP Units Stock repurchase program Issuance of shares under employee stock purchase plan
from December 31, 1998 to December 31, 1999 Issuance and cancellation of restricted stock Issuance of preferred stock Conversion of OP Units into common stock Issuance of shares of employee stock purchase plan
from December 31, 1997 to December 31, 1998 Issuance of restricted stock Issuance of shares for option exercise and employee stock purchase plans
from February 12, 1997 to December 31, 1997 Proceeds from Initial Public Offering Issuance of shares in exchange for note Issuance of shares for acquisition Issuance of restricted stock Proceeds from follow-on offering